Literature DB >> 1861207

Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre.

P C Rowe1, E Orrbine, G A Wells, P N McLaine.   

Abstract

OBJECTIVE: To define the epidemiologic features of childhood hemolytic-uremic syndrome (HUS) on a national level in Canada, to determine the proportion of patients in whom Escherichia coli O157:H7 was isolated from stools, and to examine risk factors for more severe HUS.
DESIGN: From January 1986 to December 1988, patients with HUS were reported prospectively to the Canadian Pediatric Kidney Disease Reference Centre, a national registry for pediatric renal disorders, or were identified retrospectively through a medical records search at participating institutions.
SETTING: All children's hospitals in Canada and the children's wards of general hospitals in Canadian cities with populations greater than 350,000. PATIENTS: Two hundred twenty-six children, including 126 girls.
MEASUREMENTS AND MAIN RESULTS: The average annual incidence of HUS in children younger than 15 years was 1.44 per 100,000; the peak age-specific incidence was 3.11 per 100,000 younger than 5 years. The incidence of HUS varied by region; the risk of HUS in Alberta was 2.9 times that in Ontario (p less than 0.0001). Of the 169 patients whose stools were screened, E. coli O157:H7 was isolated in 87 (51%). Risk factors for prolonged dialysis or death included young age, seizures, elevated white blood cell count at admission to hospital, and shorter, more severe prodromal illness. The rate of dialysis was higher in female patients (55% vs 39%; p = 0.02).
CONCLUSIONS: HUS is relatively common in Canadian children younger than 5 years, and is strongly associated with E. coli O157:H7 infection. Reasons for the striking regional variation in the incidence of HUS and for the increased rate of dialysis in female patients are unexplained and deserve further investigation.

Entities:  

Mesh:

Year:  1991        PMID: 1861207     DOI: 10.1016/s0022-3476(05)80730-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  42 in total

1.  Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood.

Authors:  P C Rowe
Journal:  Can J Infect Dis       Date:  1995-03

2.  Diarrhea-associated hemolytic uremic syndrome in southern Alberta: A long-term single-centre experience.

Authors:  Silviu Grisaru; Julian P Midgley; Lorraine A Hamiwka; Andrew W Wade; Susan M Samuel
Journal:  Paediatr Child Health       Date:  2011-06       Impact factor: 2.253

3.  Evaluation of BBL CHROMagar O157 versus sorbitol-MacConkey medium for routine detection of Escherichia coli O157 in a centralized regional clinical microbiology laboratory.

Authors:  D L Church; D Emshey; H Semeniuk; T Lloyd; J D Pitout
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

4.  Comparison of the western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to verocytotoxin 1.

Authors:  D Reymond; M A Karmali; I Clarke; M Winkler; M Petric
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells.

Authors:  S Arab; M Murakami; P Dirks; B Boyd; S L Hubbard; C A Lingwood; J T Rutka
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

Review 6.  Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.

Authors:  B E Mahon; P M Griffin; P S Mead; R V Tauxe
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

7.  Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera.

Authors:  S Watarai; K Yokota; T Kishimoto; T Kanadani; K Taketa; K Oguma
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

8.  A case of hemolytic uremic syndrome preceded by intussusception.

Authors:  Eun Young Ko; Joo Young Kim; Hye Jin Lee; Hyun Seung Lee; Ji Whan Han; Young Hoon Kim; Jin Tack Kim; Hae Il Cheong; Pil Sang Jang
Journal:  Korean J Pediatr       Date:  2011-04-30

9.  Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli.

Authors:  K Ramotar; E Henderson; R Szumski; T J Louie
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

10.  Enteric and foodborne disease in children: A review of the influence of food- and environment-related risk factors.

Authors:  P N Sockett; F G Rodgers
Journal:  Paediatr Child Health       Date:  2001-04       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.